Beta receptor occupancy. Assessment in the intact animal

The Journal of Clinical Investigation
C HomcyS Kopiwoda


Organ uptake of 125I-hydroxybenzylpindolol, a potent beta adrenergic antagonist, was determined after intravenous administration. Pretreatment with the beta agonist, epinephrine, inhibited an almost identical fraction of 125I-hydroxybenzylpindolol binding as did the antagonist, propranolol. Specific beta receptor binding accounted for 50% of total uptake in the lung and demonstrated the following characteristics. The dose-response curve for propranolol inhibition of 125I-hydroxybenzylpindolol binding duplicated that reported for its physiologic action. Simultaneous serum propranolol levels as determined by a sensitive radioimmunoassay allowed an apparent dissociation rate constant approximately 7 nM to be obtained that correlated closely with the results reported from membrane binding studies. Alpha blockade had no effect and inhibition of 125I-hydroxybenzylpindolol binding by propranolol demonstrated stereospecificity. After chemical sympathectomy with reserpine or 6-OH dopamine, there was a 100% increase in receptor specific binding. Finally, a scintillation camera was employed to visually and quantitatively detect 125I-hydroxybenzylpindolol displacement from the lung during intravenous propranolol administration in the livin...Continue Reading


Feb 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·R J Lefkowitz, L T Williams
Jan 1, 1978·Biochemical Pharmacology·J HoebekeA D Strosberg
Sep 23, 1977·Biochemical and Biophysical Research Communications·G Glaubiger, R J Lefkowitz
Jul 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·A LevitzkiM L Steer
Jan 11, 1974·Nature·P CuatrecasasK J Chang

❮ Previous
Next ❯


Sep 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·A J SchreursF P Nijkamp
Aug 26, 1999·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·A J Fischman
Oct 1, 1981·The New England Journal of Medicine·H J Berger, B L Zaret
Jul 1, 1982·The New England Journal of Medicine·H J Motulsky, P A Insel
May 1, 1981·The Journal of Clinical Investigation·R A BergR G Crystal
May 1, 1982·The Journal of Clinical Investigation·C J HomcyE Haber
Nov 1, 1983·The Journal of Allergy and Clinical Immunology·J J Krzanowski, A Szentivanyi
Jan 1, 1986·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·B HughesB E Sobel
May 15, 1991·Hospital Practice·C J Homcy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.